Covered recipient · General Payments record
JOY S VIARS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$3,731.63
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $612.29 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $209.02 | 5 |
| Abbott Laboratories | $179.20 | 3 |
| Amgen Inc. | $122.10 | 6 |
| Medtronic, Inc. | $49.88 | 2 |
| Novo Nordisk AS | $29.55 | 1 |
| PFIZER INC. | $22.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $141.67 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125344603 | CMS |
| Abbott Laboratories | $11.99 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125344599 | CMS |
| Abbott Laboratories | $25.54 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125344601 | CMS |
| Amgen Inc. | $19.80 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117406834 | CMS |
| Amgen Inc. | $14.35 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117406836 | CMS |
| Amgen Inc. | $14.29 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117406838 | CMS |
| Amgen Inc. | $22.87 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117406840 | CMS |
| Amgen Inc. | $32.75 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117406842 | CMS |
| Amgen Inc. | $18.04 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117406844 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.95 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105716666 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.84 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105467441 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.33 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105501270 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.67 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105696176 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.23 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105344201 | CMS |
| Medtronic, Inc. | $26.14 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117011825 | CMS |
| Medtronic, Inc. | $23.74 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117011827 | CMS |
| Novo Nordisk Inc | $29.55 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100358134 | CMS |
| PFIZER INC. | $22.54 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132104511 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.